Gulati HK, Joshi AR, Anand M, Deshmukh SD
[13] Complications [edit] Gastroparesis can lead to difficult glycemic control (which exacerbates gastric dysmotility), aspiration, bezoar formation, abnormalities in fluid and electrolyte balance, and inadequate nutrition intake resulting in weight loss
In contrast, Ozempic and Wegovy primarily work by dulling appetite, with less emphasis on broader metabolic resilience
By improving glucose control and reducing body mass, GLP-1 therapy: Eases Kidney Workload: Stable sugars mean less internal sugar coating of kidney structures
We utilised a 1:1 propensity matching strategy to establish comparable groups of patients treated with different glucose-lowering drugs, including GLP-1RA, SGLT2 inhibitors and metformin
The goal was to create science-backed blends that felt at home in a daily routine, not a medicine cabinet